Skip to main content
Journal of Clinical Outcomes Management
ALL Specialities
ALL Specialities
/
Journal of Clinical Outcomes Management
COVID-19 Updates
CME
Reviews
Case-Based Reviews
Clinical Review
QI
Clinical Communication
Original Research
Outcomes Research in Review
Reports From the Field
Diseases & Conditions
Diabetes
Infectious Diseases
Mental Health
Obesity
Pain
Specialties
Dermatology
Emergency Medicine
Pediatrics
Neurology
Surgery
Subspecialties
Cardiology
Critical Care
Gastroenterology
Geriatrics
Hematology
Oncology
Pulmonology
Rheumatology
Women's Health
News
Conference Coverage
Latest News
News by Conference
News from the FDA/CDC
Conference Coverage
Diabetic neuropathic pain linked to brain bioenergic anomalies
Publish date: October 19, 2020
FROM EASD 2020
SOURCE:
Sloan S et al. EASD 2020,
oral presentation 181
.
Pages
« first
1
2
Recommended Reading
Does metformin reduce risk for death in COVID-19?
Journal of Clinical Outcomes Management
DAPA-CKD: SGLT2 inhibitor benefit extends to chronic kidney disease without diabetes
Journal of Clinical Outcomes Management
Black diabetics lose limbs at triple the rate of others. Here’s how health care leaders are starting to act.
Journal of Clinical Outcomes Management
FDA OKs new ‘artificial pancreas’ Medtronic 770G
Journal of Clinical Outcomes Management
Pesco-Mediterranean diet, fasting ‘ideal’ to reduce CVD risk
Journal of Clinical Outcomes Management
Exercise cuts diabetes death risk by a third in two studies
Journal of Clinical Outcomes Management
Higher glycemic time in range may benefit T2D patients
Journal of Clinical Outcomes Management
AHA scientific statement highlights cardiorenal benefit of new diabetes drugs
Journal of Clinical Outcomes Management
Dapagliflozin’s CKD performance sends heart failure messages
Journal of Clinical Outcomes Management
Recall widens for diabetes drug metformin
Journal of Clinical Outcomes Management
Diabetes
Pain
All Specialties
